Anti-atherogenic effects of montelukast associated with reduced MCP-1 expression in a rabbit carotid balloon injury model
- 31 July 2009
- journal article
- Published by Elsevier BV in Atherosclerosis
- Vol. 205 (1), 74-79
- https://doi.org/10.1016/j.atherosclerosis.2008.11.012
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Expression of 5-lipoxygenase and leukotriene A 4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instabilityProceedings of the National Academy of Sciences of the United States of America, 2006
- Treatment of asthma with antileukotrienes: First line or last resort therapy?European Journal of Pharmacology, 2006
- Cysteinyl leukotrienes induce monocyte chemoattractant protein 1 in human monocytes/macrophagesClinical and Experimental Allergy, 2005
- Association Between 5-Lipoxygenase Expression and Plaque Instability in HumansArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- The 5-lipoxygenase pathway promotes pathogenesis of hyperlipidemia-dependent aortic aneurysmNature Medicine, 2004
- Differential Leukotriene Receptor Expression and Calcium Responses in Endothelial Cells and Macrophages Indicate 5-Lipoxygenase–Dependent Circuits of Inflammation and AtherogenesisArteriosclerosis, Thrombosis, and Vascular Biology, 2003
- Expanding expression of the 5-lipoxygenase pathway within the arterial wall during human atherogenesisProceedings of the National Academy of Sciences of the United States of America, 2003
- Prostaglandins and Leukotrienes: Advances in Eicosanoid BiologyScience, 2001
- Atherosclerosis — An Inflammatory DiseaseNew England Journal of Medicine, 1999
- Leukotrienes and Lipoxins: Structures, Biosynthesis, and Biological EffectsScience, 1987